Hernia repair remains one of the most common surgical procedures worldwide, with synthetic polymer meshes widely used to support damaged tissues. Despite their clinical success, current implants are still associated with complications such as inflammation, adhesion, mechanical mismatch and postoperative pain. This review explores the evolution of hernia mesh implants, focusing on material selection, design strategies, mechanical requirements and clinical limitations of commercial solutions. Special attention is given to the electrospinning technique as a promising approach for fabricating nanofibrous scaffolds that mimic the extracellular matrix (ECM) and allow the integration of therapeutic agents. The fundamental principles, equipment configuration and process parameters of electrospinning are discussed, along with recent innovations in drug-releasing and bioactive meshes. Advances in polymer science have enabled the fabrication of partially biodegradable meshes combining synthetic and natural materials, which aim to enhance tissue regeneration while minimizing adverse foreign body responses. Comparative analyses of mechanical properties between electrospun nonwovens, native soft tissues and commercial meshes highlight the potential of nanofibrous materials to provide sufficient mechanical strength and improved isotropy. Furthermore, in vitro and in vivo studies demonstrate the biocompatibility and regenerative capacity of electrospun implants. While no universal solution has yet been achieved, electrospun meshes represent a promising direction in the design of next-generation implants for hernia treatment. Their ability to combine tunable mechanical performance, controlled drug release and ECM-like morphology may ultimately lead to improved clinical outcomes and reduced complication rates.
扫码关注我们
求助内容:
应助结果提醒方式:
